Skip to content

Sanara MedTech Inc. SMTI Income from Continuing Ops

Income from Continuing Ops at other companies

Sharplink, Inc.
 logo
Sharplink, Inc. SBET
-$685.56M-74,661%
Helen Of Troy logo
Helen Of TroyHELE
-$84.06M-269%
Quanex Building Products logo
Quanex Building ProductsNX
$7.12M-73.5%
Liberty Broadband Corporation logo
Liberty Broadband CorporationLBRDK
$1.42-13.4%
908 Devices logo
908 DevicesMASS
-$0.32-14.3%
Bakkt
 logo
Bakkt BKKT
-$1.64+9.9%

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsPerBasicShare.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s income from continuing ops.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s income from continuing ops?
Sanara MedTech Inc. (SMTI) reported income from continuing ops of $0.04 in Q1 2026.
How has Sanara MedTech Inc.'s income from continuing ops changed year-over-year?
Sanara MedTech Inc.'s income from continuing ops increased by 157.1% year-over-year, from -$0.07 to $0.04.
What does income from continuing ops mean?
Net income from business operations that are expected to continue, excluding gains or losses from discontinued segments. The best measure of ongoing earning power.